Association of COVID-19 Vaccine with Relapsed Nephrotic Syndrome and New Onset Nephrotic Syndrome in Children
Friday, May 3, 2024
4:00 PM – 4:15 PM ET
Location: Metro Toronto Convention Centre: 803 B
CE Enduring CME: 0.25
Publication Number: 1055.2
Dayna Mazza, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Elizabeth Ward, Childrens Hospital of Philadelphia, Missouri City, TX, United States; Jarcy Zee, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Spandana Makeneni, Childrens Hospital of Philadelphia, Phildelphia, PA, United States; Michelle Denburg, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Benjamin L. Laskin, Childrens Hospital of Philadelphia, Philadelphia, PA, United States
Presenting Author(s)
Dayna Mazza, MD, MSHP (she/her/hers)
Assistant Professor of Clinical Pediatric Nephrology Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Dayna Mazza, MD, MSHP: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Elizabeth Ward, n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jarcy Zee, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Spandana Makeneni, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Michelle Denburg, MD, MSCE: Mallinckrodt (Terminated, December 31, 2021) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Benjamin L. Laskin, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
